FDA Clears IMRIS’ VISIUS Surgical Theatre Imaging System

Minnetonka, Minn.-based IMRIS received clearance from the U.S. Food and Drug Administration for the next generation of its VISIUS Surgical Theatre, an intraoperative imaging system.

Advertisement

VISIUS Surgical Theatre is a transportable magnetic resonance and computed tomography imaging system. Surgeons can request the system be brought to the operating room if necessary during a procedure, eliminating the need to move the patient for imaging and reducing the risk of patient harm, according to IMRIS‘ website.

This latest generation that received FDA clearance integrates Munich, Bavaria-based Siemens’ latest MR scanners and will “deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition and improved ease of use and workflow during neurosurgical procedures using intraoperative MRI,” according to the news release.

More Articles on FDA Cleared Devices:

FDA Clears Given Imaging’s PillCam COLON for Incomplete Colonoscopies
Sofosbuvir Earns FDA Approval as Hepatitis C Treatment
FDA Approves Medtronic’s CoreValve Transcatheter Without Panel Review

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.